{"id":60212,"date":"2024-10-22T16:04:28","date_gmt":"2024-10-22T14:04:28","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/"},"modified":"2024-10-22T16:04:28","modified_gmt":"2024-10-22T14:04:28","slug":"enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/","title":{"rendered":"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call"},"content":{"rendered":"<div>\n<p>CHARLOTTE, N.C.&#8211;(BUSINESS WIRE)&#8211;Enpro Inc. (NYSE: NPO) will release financial results for the third quarter of 2024, on Tuesday, November 5, at 6:30 a.m. Eastern Time. Eric Vaillancourt, President and Chief Executive Officer, and Joe Bruderek, Executive Vice President and Chief Financial Officer, will host a conference call to review the company\u2019s performance at 8:30 a.m. Eastern Time.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/5\/Enpro-Horiztonal-CMYK-01.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/5\/Enpro-Horiztonal-CMYK-01.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/21\/Enpro-Horiztonal-CMYK-01.jpg\"><\/a><\/p>\n<p>\nThe conference call will be webcast live at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.enpro.com&amp;esheet=54139435&amp;newsitemid=20241022048739&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.enpro.com&amp;index=1&amp;md5=447954b55208f397a2260f37efddfaaa\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/www.enpro.com<\/a>, and by telephone at 1-877-407-0832, using the access code 13735653, approximately 10 minutes before the call. Third quarter 2024 financial results and the accompanying slide presentation will be available on the company\u2019s website.\n<\/p>\n<p>\n<b>About Enpro<\/b>\n<\/p>\n<p>\nEnpro is a leading industrial technology company focused on critical applications across many end-markets, including semiconductor, industrial process, commercial vehicle, sustainable power generation, aerospace, food and pharma, photonics and life sciences. Headquartered in Charlotte, North Carolina, Enpro is listed on the New York Stock Exchange under the symbol \u201cNPO\u201d. For more information about Enpro, visit the company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.enpro.com&amp;esheet=54139435&amp;newsitemid=20241022048739&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.enpro.com&amp;index=2&amp;md5=f0806be743abe6c2ac04784e610301b5\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/www.enpro.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contacts:<\/b>\n<\/p>\n<p>\nJames Gentile<br \/>\n<br \/>Vice President, Investor Relations\n<\/p>\n<p>\nJenny Yee<br \/>\n<br \/>Corporate Access Specialist\n<\/p>\n<p>\n<b>Phone: <\/b>704-731-1527\n<\/p>\n<p>\n<b>Email:<\/b> <a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#58;i&#x6e;&#118;e&#x73;&#116;o&#x72;&#46;r&#x65;&#108;&#x61;&#x74;&#105;&#x6f;&#x6e;&#115;&#x40;&#101;n&#x70;&#114;o&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;n&#x76;&#101;s&#x74;&#111;&#x72;&#46;r&#x65;&#108;&#x61;&#116;i&#x6f;&#110;&#x73;&#x40;e&#x6e;&#112;r&#x6f;&#46;&#x63;&#111;m<\/a>\n<\/p>\n<p>\n<b>Enpro Inc.<\/b><br \/>5605 Carnegie Boulevard<br \/>\n<br \/>Charlotte, NC 28209<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.enpro.com&amp;esheet=54139435&amp;newsitemid=20241022048739&amp;lan=en-US&amp;anchor=www.enpro.com&amp;index=3&amp;md5=771bfd18ef3e93168f67ae60c9ff48da\" rel=\"nofollow noopener\" shape=\"rect\">www.enpro.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLOTTE, N.C.&#8211;(BUSINESS WIRE)&#8211;Enpro Inc. (NYSE: NPO) will release financial results for the third quarter of 2024, on Tuesday, November 5, at 6:30 a.m. Eastern Time. Eric Vaillancourt, President and Chief Executive Officer, and Joe Bruderek, Executive Vice President and Chief Financial Officer, will host a conference call to review the company\u2019s performance at 8:30 a.m. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60212","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHARLOTTE, N.C.&#8211;(BUSINESS WIRE)&#8211;Enpro Inc. (NYSE: NPO) will release financial results for the third quarter of 2024, on Tuesday, November 5, at 6:30 a.m. Eastern Time. Eric Vaillancourt, President and Chief Executive Officer, and Joe Bruderek, Executive Vice President and Chief Financial Officer, will host a conference call to review the company\u2019s performance at 8:30 a.m. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-22T14:04:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call\",\"datePublished\":\"2024-10-22T14:04:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/\"},\"wordCount\":213,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241022048739\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/\",\"name\":\"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241022048739\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\",\"datePublished\":\"2024-10-22T14:04:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241022048739\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241022048739\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Pharma Trend","og_description":"CHARLOTTE, N.C.&#8211;(BUSINESS WIRE)&#8211;Enpro Inc. (NYSE: NPO) will release financial results for the third quarter of 2024, on Tuesday, November 5, at 6:30 a.m. Eastern Time. Eric Vaillancourt, President and Chief Executive Officer, and Joe Bruderek, Executive Vice President and Chief Financial Officer, will host a conference call to review the company\u2019s performance at 8:30 a.m. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/","og_site_name":"Pharma Trend","article_published_time":"2024-10-22T14:04:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call","datePublished":"2024-10-22T14:04:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/"},"wordCount":213,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/","url":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/","name":"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","datePublished":"2024-10-22T14:04:28+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20241022048739\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/enpro-announces-date-for-third-quarter-2024-earnings-release-and-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Enpro Announces Date for Third Quarter 2024 Earnings Release and Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60212"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60212\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}